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Abstract
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive degeneration of
motor neurons. Substantial evidence implicates oxidative stress and mitochondrial dysfunction as early events in disease
progression. Our aim was to ascertain whether mutation of the SOD1 protein increases metabolic functional susceptibility
to oxidative stress. Here we used a motor neuron-like cell line (NSC34) stably transfected with various human mutant SOD1
transgenes (G93A, G37R, H48Q) to investigate the impact of oxidative stress on cell viability and metabolic function within
intact cells. NSC34 cells expressing mutant SOD1 showed a dose dependent reduction in cell viability when exposed to
oxidative stress induced by hydrogen peroxide, with variation between mutations. The G93A transfectants showed greater
cell death and LDH release compared to cells transfected with the other SOD1 mutations, and H48Q showed an accelerated
decline at later time points. Differences in mitochondrial bioenergetics, including mitochondrial respiration, coupling
efficiency and proton leak, were identified between the mutations, consistent with the differences observed in viability.
NSC34 cells expressing G93A SOD1 displayed reduced coupled respiration and mitochondrial membrane potential
compared to controls. Furthermore, the G93A mutation had significantly increased metabolic susceptibility to oxidative
stress, with hydrogen peroxide increasing ROS production, reducing both cellular oxygen consumption and glycolytic flux in
the cell. This study highlights bioenergetic defects within a cellular model of ALS and suggests that oxidative stress is not
only detrimental to oxygen consumption but also glycolytic flux, which could lead to an energy deficit in the cell.
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Introduction
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenera-
tive disorder, characterized by the progressive degeneration of
upper and lower motor neurons [1,2]. The majority of ALS cases
are sporadic but around 10% are familial in origin [3]. Cu/Zn
Superoxide Dismutase 1 (SOD1) was the first gene identified as
mutated in ALS [4], and accounts for approximately 2% of all
ALS cases [5,6]. SOD1 is a ubiquitously expressed metalloenzyme
that catalyses the dismutation of superoxide radicals into hydrogen
peroxide and molecular oxygen. Mutant SOD1 is toxic by a
mechanism that is independent of its dismutase activity [7]. The
identification and characterization of mutations in SOD1 has led to
the development of in vitro and in vivo models from which have
emerged much of our current understanding of the pathophysi-
ological mechanisms involved in ALS [8].
Mitochondria form highly dynamic networks and are the
primary site of ATP production through oxidative phosphoryla-
tion [9,10]. These metabolic reactions are major sources of
reactive oxygen species (ROS), which can inflict damage to
macromolecules. A characteristic manifestation of neurodegener-
ative disease is mitochondrial dysfunction and studies from both
ALS patients and transgenic animal models have demonstrated
changes in mitochondrial function including a reduction in the
activity of respiratory chain complexes and decline of mitochon-
drial bioenergetic capacity [11,12,13]. A functional compromise to
energy production results in a loss of mitochondrial membrane
potential, in addition to impaired electron chain transport activity
and a reduction in ATP production, with an accompanying
increase in ROS production [13,14,15]. In vitro studies have shown
that the transfection of human mutant SOD1 variants can cause a
shift in redox potential, an increase in mitochondrial superoxide
dismutase levels, increased toxicity, and a reduction in respiratory
chain complex activity [16,17,18]. In vivo murine studies have also
demonstrated the vulnerability of mitochondria together with
disturbances to calcium homeostasis in the presence of human
G93A mutant SOD1 [19,20]. Although mitochondrial impairment
and increased oxidative stress have been extensively documented
in models of ALS, the causal relationship between impaired
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bioenergetics, physiological malfunction, and oxidative damage
needs to be further established in relation to the underlying
pathogenesis of ALS.
In this study we utilised the murine neuroblastoma motor
neuron (NSC34) hybrid cell line [21], stably transfected with
human mutant SOD1 transgenes. SOD1 mutations in these cell
lines have previously been shown to increase oxidative stress and
mitochondrial dysfunction, with key genes down regulated in their
metabolic pathways [14,22]. We expressed wild-type human SOD1
(WTSOD1), G93A mutant human SOD1, H48Q mutant human
SOD1, G37R mutant human SOD1, and a pIRES vector control in
the NSC34 cell line and determined the effect on the susceptibility
to oxidative stress in terms of cell viability, mitochondrial and
metabolic function. We show that expression of human G93A and
H48Q SOD1 mutations renders neuronal cells more susceptible to
oxidative stress in terms of viability and significant differences in
mitochondrial bioenergetics are identified in the G93A mutant
SOD1 cells compared with the controls and other mutations
investigated, both under basal and stress conditions.
Methods
Cell Culture
NSC34 mouse motor neuron cells [21] (a gift from Dr Neil
Cashman, University of British Columbia, Canada) were stably
transfected with pIRESneo (Clontech, Saint-Germain, France)
using Lipofectamine 2000 (Invitrogen). Cells were transfected with
empty vector (pIRES cells) or pIRESneo containing wild-type
human SOD1 (WTSOD1 cells), human SOD1 mutant G93A,
human SOD1 mutant G37R, or human SOD1 mutant H48Q.
Geneticin (G418, Invitogen) at 250 mg/ml was added to cells 24
hours later to select for transfected cells. The expression levels for
the human SOD1 transgenes were determined by real time
quantitative PCR (RT-qPCR) as described elsewhere [22]. The
level of human SOD1 in each of the cell lines was determined by
measuring the difference in the deltaCt between the human SOD1
and mouse Sod1 transcripts [23]. Western blotting was used to
determine the protein levels of human and mouse SOD1 in the
NSC34 cells using a sheep anti-SOD1 (Cu/Zn) polyclonal antibody
(1:1000, Calbiochem, Nottingham, UK).
Cell Viability Assay
NSC34 pIRES vector control, WTSOD1, G37R, H48Q and
G93A cells were plated into 6 cm diameter petri-dishes and
cultured under normal growth conditions in DMEM 4.5 mg/ml
glucose (Sigma) supplemented with 10% Biosera Fetal Calf Serum,
2 mM glutamine (Lonza) and G418 (250 mg/ml) at 37uC/5%
CO2, until they reached 70–80% confluency. Cells were treated
with hydrogen peroxide (H2O2) at concentrations ranging from
50 mM to1 mM for two, four, six, and ten hours. The assay was
performed under normal growth conditions and the effect of
oxidative insult on cell viability was measured using 0.4% trypan
blue dye exclusion (Sigma) and a Coulter Cell Counter (Invitro-
gen).
Lactate Dehydrogenase Assay
NSC34 pIRES vector control, WTSOD1, G37R, H48Q and
G93A cells were plated into 96 well plates and incubated for 24
hours under normal growth conditions in DMEM 4.5 mg/ml
glucose (Sigma) supplemented with 10% Biosera Fetal Calf Serum,
2 mM glutamine and G418 (250 mg/ml) at 37uC/5% CO2. Cells
were treated with 250 mM, 500 mM and 1 mM H2O2 for two,
four, six, and ten hours. The assay was performed under normal
growth conditions and the effect of oxidative insult on lactate
dehydrogenase (LDH) was measured. The culture medium was
collected and LDH release was measured using a CytoTox 96H
Non-Radioactive Cytotoxicity Assay (Promega, G1780). Briefly,
post stress, 50 ml of culture media was removed and added to
50 ml of assay substrate mix, incubated at room temperature in the
dark for 15 minutes then the absorbance was recorded at 490 nM
on a Fluorostar Omega plate reader (BMG Labtech). Total LDH
was assessed by freeze thawing the assay plate and repeating the
procedure described above. Percentage LDH release was calcu-
lated using the following formula, % LDH release = (H2O2
induced LDH release/Total LDH)6100.
Seahorse Metabolic Assay
NSC34 pIRES vector control, WTSOD1, G37R, H48Q and
G93A cells were plated in a 24 well Seahorse cell culture plate
(Seahorse Bioscience, 100777-004) in 250 ml DMEM 4.5 mg/ml
glucose supplemented with 10% Biosera fetal calf serum, 2 mM
glutamine and 250 mg/ml G418. The cells were incubated at
37uC/5% CO2 overnight. The following day the media was
removed and replaced with XF assay media pH 7.4 (Seahorse
Bioscience 101022-100) supplemented with 2 mM glutamine and
4.5 mg/ml glucose. Cells were incubated at 37uC for 1 hour.
Meanwhile, a 24 well microplate was loaded with 5.0 mg/ml
oligomycin (Sigma) final concentration 0.5 mg/ml, 2.50 mM
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)
(Sigma) 0.25 mM final concentration, and 5.0 mM Rotenone
(Sigma) final concentration 0.5 mM. All were made up in XF assay
media as described above. The microplate was calibrated in a
Seahorse XF24 analyzer prior to addition of the cell culture plate.
Three basal measurements were recorded (three minutes each)
prior to addition of oligomycin, FCCP and finally rotenone. The
effect of the drugs on oxygen consumption and ECAR were
measured three times (3 minutes each). Cell number was
normalized by addition of 4.0 mM calcein (Invitrogen), which
was incubated with the cells for 30 minutes and fluorescence
measured on a Fluorostar Omega plate reader (BMG Labtech) at
Ex485 nm/Em530 nm. For the stress assays, the cells were
incubated with 50, 100 and 200 mM H2O2 for one hour at
37uC/5% CO2 prior to preparation of the cells for analysis on the
XF 24 bioanalyser as described above.
Mitochondrial Membrane Potential Assay
NSC34 cells were plated at 15,000 cells per well in a gelatin
coated (0.5 mg/ml gelatin overnight at 4uC) 96 well plate in
200 ml DMEM 4.5 mg/ml glucose supplemented with 10%
Biosera fetal calf serum, 2 mM glutamine and 250 mg/ml G418,
then incubated at 37uC/5% CO2. 24 hours later, the media was
removed and replaced with glucose free DMEM media (Lonza)
+10% FCS +0.9 mg/ml galactose. After a further 23 hours,
10 mM FCCP in 40% ethanol was added to half the wells to
dissipate the mitochondrial membrane potential. Cells were
incubated at 37uC/5% CO2 for 1 hour, the media was then
removed and the cells were incubated with 150 nM tetramethylr-
hodamine methyl ester (TMRM, Sigma) for 15 minutes at 37uC/
5% CO2. Cells were then washed three times with 150 ml 16PBS.
The plate was read on a BMG Fluorostar plate reader at
Ex544 nm/Em590 nm for TMRM fluorescence. Cell death was
simultaneously measured by adding 0.3 mM ethidium homodimer-
1(EthD1, Molecular Probes) to the culture medium and measuring
fluorescence at Ex530 nm/Em645 nm. TMRM fluorescence was
normalized to cell number, determined by measuring EthD1
fluorescence (0.3 mM) after cells had been freeze–thawed. Mito-
chondrial membrane potential was calculated by subtracting the
TMRM fluorescence in the presence of FCCP (plasma membrane
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potential contribution) from the fluorescence in the absence of
FCCP.
H2O2 Oxidative Stress Assay
NSC34 cells were grown in gelatin coated 96-well tissue-culture
plates in phenol red-free DMEM (Lonza) until 70% confluent.
100 mM H2O2 was added to the cells for 60 minutes at 37uC. The
media was subsequently removed and the cells were washed twice
with 16PBS. Cytosolic reactive oxygen species levels were
measured using dichlorofluorescein (DCF) fluorescence. Car-
boxy-H2DCFDA (6-carboxy-29,79-dichlorodihydrofluorescein di-
acetate, di(acetoxymethyl ester);MolecularProbes, Paisley, UK)
was added to the NSC34 cells at 10 mM, and the fluorescence of
oxidized DCF was read at Ex485 nm/Em530 nm after 90 minutes
using a BMG Fluorostar plate reader (BMG Labtech). Cell
number was measured by adding EthD1 to the culture medium
after the cells had been freeze–thawed. Fluorescence was
measured at Ex530 nm/Em645 nm. Raw DCF data results were
then normalized to cell number.
Statistical analyses
For the cell viability assays, five replicates for each transfectant
at each time point/concentration were performed and normalized
to the viability of the untreated pIRES cells. The means/standard
deviations were calculated and a two-way ANOVA by mutation at
each concentration was performed using GraphPad Prism version
5.0d for Mac (GraphPad Software, La Jolla California USA). For
each control and mutation, the metabolic assay was carried out
four times under both basal conditions, with three technical
replicates generated per experiment. All data were normalised to
cell number prior to analysis. A one-way ANOVA with Bonferroni
post-hoc test was performed using GraphPad Prism version 5.0d
for Mac (GraphPad Software, La Jolla California USA) to
investigate changes under basal conditions and stress conditions
for each cell type individually. For each control and mutation the
metabolic assay following oxidative stress was carried out six times,
with three technical replicates generated per experiment. A two-
way ANOVA by H2O2 dose was performed to investigate the
effect of the stress on OCR/ECAR across the mutations. For the
mitochondrial membrane potential analysis, the assay was
performed seven times with a minimum of three replicates per
experiment for each control and mutant. TMRM fluorescence in
the presence of FCCP was subtracted from TMRM fluorescence
in the absence of FCCP. All data were normalized to cell number
prior to mitochondrial membrane potential calculation. A one-
way ANOVA with Bonferroni post hoc analysis test was
performed using Graph Pad Prism version 5.0d to investigate
the effect of SOD1 mutation on the NSC34 cell mitochondrial
membrane potential.
Results
Susceptibility of NSC34 cells expressing mutant SOD1
G93A to oxidative stress
An in vitro model of SOD1-mediated ALS was previously
established in our lab by generating single cell clones of NSC34
motor neuron cells stably expressing equivalent amounts of either
normal human SOD1 or the G93A mutant SOD1 [24]. The
G93A SOD1 mutant has WT dismutase activity but has increased
free radical-generating function [25]. We have previously shown a
significant increase in cytosolic oxidative stress in the NSC34 cells
expressing human G93A SOD1 compared to cells expressing the
pIRES vector or human WTSOD1 [24]. To ascertain whether
mutation of the SOD1 protein led to metabolic susceptibility to
oxidative stress, the effect of H2O2 on cell survival was
investigated. Oxidative stress was induced for two, six and ten
hours at 37uC and cell survival was assayed by trypan blue
exclusion. Increasing H2O2 led to increased cell death across all
cell lines investigated (Figure 1 A–C), with the G93A mutant
SOD1 cells displaying the greatest susceptibility to H2O2
compared to control cells at all H2O2 concentrations (Figure 1
A–C). Further analysis of the G93A mutant SOD1 cells showed a
significant increase in ROS levels above basal in the presence of
H2O2 in comparison to the controls (Figure 2A). Furthermore
when normalised to basal levels the percentage increase was
significantly higher in the G93A SOD1 cells than controls
(Figure 2B, p#0.05).
Characterization of mitochondrial function in NSC34 cells
expressing mutant SOD1 G93A
With the aim of creating a bioenergetic profile of the neuronal
cell model, the NSC34 cells were analysed on an XF-24
Extracellular Flux Analyzer (Seahorse Biosciences), which simul-
taneously monitors the two major energy-yielding pathways in
cells, aerobic respiration and glycolysis, by measuring the oxygen
consumption rate (OCR) and extracellular acidification rate
(ECAR). Cellular respiration was assessed under basal conditions
(basal respiration), with the ATP synthase inhibitor oligomycin
(coupled respiration), the mitochondrial membrane uncoupler
FCCP (to measure spare respiratory capacity) and the mitochon-
drial complex I inhibitor rotenone to assess mitochondrial specific
respiration (Figure 3A). The sequential addition of these
compounds shifts the bioenergetic profile of cells, allowing
differences in mitochondrial function to be compared between
cell lines.
Basal oxygen consumption rate (bOCR) is an indicator of both
mitochondrial and non-mitochondrial respiration and is controlled
strongly by ATP turnover and partly by substrate oxidation and
proton leak [26,27]. No significant difference in bOCR was
observed between the G93A mutant SOD1 cells and controls
(Figure 3B). The fraction of cellular oxygen consumption linked to
the mitochondria (mOCR) was measured by addition of rotenone.
No significant difference was observed between G93A SOD1 and
controls (Figure 3C). The application of FCCP dissipates the
proton gradient across the mitochondrial inner membrane and
allows investigation of maximal mitochondrial respiration. When
FCCP was added to induce maximal respiration, the calculated
spare respiratory capacity of the G93A cells was reduced
compared to controls, however the reduction was again non-
significant (p.0.05) (Figure 3D).
Together with measurements of aerobic respiration, the XF24
Seahorse bioanalyser also enables investigation of the extracellular
acidification rate (ECAR), a direct measure of lactate produced by
glycolytic flux. Moreover, the response of the glycolytic flux to
mitochondrial inhibition can be measured (Figure 4A). When ATP
synthase is inhibited, the cell responds by up-regulating glycolysis
to recover the energy deficit; this increase above basal levels is
termed the glycolytic capacity. A concomitant rise in ECAR is also
observed when injecting FCCP, which is likely to be due to the
contribution of bicarbonated CO2 to ECAR, produced by
upregulation of the TCA cycle. In terms of basal ECAR, no
difference was observed between G93A mutant SOD1 and control
cells (Figure 4B). When analysing induction of the glycolytic flux,
although glycolytic capacity was reduced by approximately 20% in
the G93A cells it did not reach significance (p.0.05) (Figure 4C).
To further investigate mitchondrial dysfunction in the G93A
cells, the mitochondrial membrane potential was measured using
the fluoresecent dye TMRM. The G93A mutant SOD1 cells had
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lower mitochondrial membrane potential compared to the pIRES
vector and WTSOD1 control cell lines (Figure 5, p#0.05).
Effect of oxidative stress on the cell viability of NSC34
cells expressing different mutant SOD1 transgenes
We now proceeded to investigate whether the susceptibility to
oxidative stress varied between different SOD1 mutations. We
therefore carried out repeat experiments using the controls and
G93A mutant SOD1 cells, alongside G37R and H48Q human
Figure 1. The effect of G93A SOD1 mutation on NSC34 cell
viability. The G93A mutation was more susceptible to oxidative stress
in terms of cell viability at A. 250 mM B. 500 mM and C. 1 mM. Cells were
incubated for 2, 6 and 10 hours with H2O2 prior to cell counting. Data
presented as mean with SD n= 5. Statistical analyses by two-way
ANOVA with Bonferroni post-test, **** = P#0.0001, *** = P#0.001
** = P#0.01* = P#0.05.
doi:10.1371/journal.pone.0068256.g001
Figure 2. The effect of H2O2 on ROS levels in NSC34 cells. A. Raw
DCF fluorescence. B. Data normalized to basal levels. Cells were treated
with 100 mM H2O2 for one hour at 37uC. Cells were washed prior to
addition of DCF for 90 minutes at 37uC. Data presented as mean with
SD n=5. Statistical analysis by A. One way ANOVA with Bonferroni post
test. B. Kruskal Wallis test with Dunns post test, ** = P#0.01, * = P#0.05.
doi:10.1371/journal.pone.0068256.g002
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mutant SOD1 transfected NSC34 cells. Previously published data
from our laboratory showed equivalent human SOD1 protein
expression levels in all transfected cell lines [24]. In addition, no
significant differences at the level of transfection for the WTSOD1
and the mutant SOD1 transgenes were detected, as determined by
RT-qPCR (Figure S1), confirming equivalent transfection through
transcription.
The effect of oxidative stress on cell viability was investigated in
controls and NSC34s expressing G93A, G37R, or H48Q human
mutant SOD1 as described previously. Little difference in cell
viability across all cell lines was seen with 50 mM and 100 mM
H2O2 treatment (data not shown). Differential vulnerability to
oxidative stress in the G93A mutation was evident when cells were
treated with 250 mM H2O2, which was observed both in
comparison to the controls and the other mutations (Figure 6A–
C). Exposure to 500 mM and 1 mM H2O2 produced a reduction
in viability such that SOD1 mutant lines displayed rapid induction
of cell death. The G93A mutation displayed a significant reduction
in cell viability with a 500 mM H2O2 exposure in comparison to
both controls and the other mutations (p#0.05), and the H48Q
mutation showed a significant reduction in viability in comparison
to controls at six and ten hours (p#0.01) (Figure 6B). The G37R
mutation showed a steady decline over time with both 500 mM
and 1 mM treatments, but retained the greatest survival at ten
hours (Figure 6C) and showed significantly greater viability than
the other mutations (p#0.001). Prolonged treatment with H2O2
(.six hours) would be expected to significantly reduce viability
across all cell types. The G93A mutant NSC34 cells were the most
severely affected, together with the H48Q mutant cells, as time
and H2O2 concentration increased. In contrast, the G37R mutant
cells displayed greater viability across all concentrations at all the
investigated time points (p#0.05). The pIRES vector and
WTSOD1 controls showed reduction in viability but these did
not become pronounced until persistent exposure to high
concentrations of H2O2.
Figure 3. The effect of G93A SOD1 mutation on oxygen consumption. A. Representative OCR bioenergetic profile of NSC34 cells. Blue-pIRES,
pink-WTSOD1, dark blue-G93A SOD1. B. Basal cellular oxygen consumption. C. Mitochondrial oxygen consumption. Mitochondrial respiration was
calculated by subtracting OCR in the presence of rotenone from basal OCR. D. Spare respiratory capacity was calculated by subtracting maximal
respiration from mitochondrial respiration.
doi:10.1371/journal.pone.0068256.g003
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To further investigate the effect of oxidative stress on cellular
injury, lactate dehydrogenase (LDH) release from the cell was
measured to quantitatively measure cell lysis in the presence of
H2O2. No difference in LDH release was observed between
mutants and controls following a two-hour treatment with 250,
500 and 1 mM H2O2 (Figure 6 D–F). Treating with 250 mM
H2O2 for four and six hours, led to a significant increase in LDH
release in the G93A mutant compared to the control and H48Q/
G37R mutant cell lines (p#0.01). A similar trend was also
observed when treating with 500 mM and 1 mM H2O2. The
G37R mutant cells displayed comparable LDH release to the
controls at the time points and H2O2 tested, which was consistent
with the trypan blue cell viability data following H2O2 treatment
(Figure 6 A–C). The H48Q mutant cells in general showed greater
LDH release than controls at 250 mM H2O2. However at higher
concentrations no differences were observed between the mutant
and controls.
Comparing mitochondrial bioenergetics of NSC34 cells
expressing different mutant SOD1 transgenes
Metabolic assays as described for the G93A mutation were
carried out in the additional SOD1 mutant cells to compare
mitochondrial bioenergetics between different SOD1 mutations.
The experimental set-up was identical to that for the G93A
mutant SOD1 versus control assays, with the controls and G93A
mutant SOD1 cells included. The results for the G93A mutation
replicated our original findings, a non-significant (p.0.05)
reduction in bOCR was observed between the G93A mutant
and control cells. However, differences were observed between the
mutations. bOCR was significantly lower in the G93A mutant
cells in comparison to the G37R mutant cells (p#0.01) (Figure 7A),
indicating different effects of SOD1 mutations on mitochondrial
metabolism. G37R mutant cells also showed higher bOCR than
WTSOD1, this was shown to be mitochondrial specific as when
rotenone was used to determine the fraction of cellular oxygen
consumption linked to the mitochondria, the G37R mutant cells
showed significantly higher (p#0.01) mitochondrial respiration
compared with WTSOD1 and G93A SOD1 cells (Figure 7B). The
Figure 4. The effect of G93A SOD1 mutation on glycolytic flux.
A. Representative ECAR bioenergetic profile of NSC34 cells. Blue-pIRES,
pink-WTSOD1, dark blue-G93A SOD1. B. Basal ECAR. C. ECAR induction
with addition of oligomycin (Oligo) and FCCP. P = pIRES. Data presented
as mean with SD n=5.
doi:10.1371/journal.pone.0068256.g004
Figure 5. The effect of G93A SOD1 mutation on mitochondrial
membrane potential. Membrane potential was measured using
150 nM TMRM for 15 minutes at 37uC 2/+10 mM FCCP. Data presented
as mean with SD n= 7. Statistical analyses by one-way ANOVA with
Bonferroni post-test, * = P,0.05.
doi:10.1371/journal.pone.0068256.g005
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spare respiratory capacity of the G93A cells was reduced
compared to the other SOD1 mutations and controls (as shown
previously), however the reduction was not significant (p.0.05,
data not shown).
Figure 6. The effect of SOD1 mutation on NSC34 cell viability. A-C. Trypan blue exclusion assays. The G93A mutation was the most
susceptible to oxidative stress, exhibiting significant reductions in cell viability in comparison to controls at 250 mM, 500 mM and 1 mM H2O2. The
G37R mutation showed the greatest resistance to the stress, with significantly increased viability in comparison to the G93A and H48Q mutations.
Data presented as mean with SD (n = 5). Statistical analyses by two-way ANOVA with Bonferroni post-test, all significant values presented are P#0.01.
(Key A-C graphs: &=pIRES v G93A, a=pIRES v H48Q, &=WTSOD1 v pIRES, #=WTSOD1 v G93A, l=WTSOD1 v H48Q, 3=WTSOD1 v H48Q,
w=H48Q v G93A, ‘=G37R v pIRES, +=G37R v WTSOD1, &=G37R v G93A, X =G37R v H48Q). D-F. LDH cytotoxcity assays. LDH release was
measured over two-10 hours at D.250 mM. E 500 mM. F.1 mM H2O2. The G93A mutation generally showed the greatest LDH release compared to the
controls and G37R/H48Q mutations. The G37R mutation showed a similar LDH release to that of controls across all time points and stress conditions.
Data presented as mean with SD (n = 4). Statistical analyses by two-way ANOVA with Bonferroni post-test, **** = P,0.0001, *** = P,0.001,
** = P,0.01, * = P,0.05.
doi:10.1371/journal.pone.0068256.g006
Metabolic Profiling of SOD1 Mutations
PLOS ONE | www.plosone.org 7 June 2013 | Volume 8 | Issue 6 | e68256
Figure 7. The effect of the SOD1 mutation on cellular respiration. A. Basal OCR (bOCR). B. Mitochondrial OCR (mOCR) calculated by
subtracting OCR in the presence of rotenone from bOCR. The G37R mutation showed significantly higher bOCR and mOCR than WTSOD1 and G93A
SOD1. C. Oligomycin sensitive respiration (coupled mitochondrial respiration). The rate of ATP turnover (coupled respiration) in a basal state can be
determined from the decrease in OCR in the presence of oligomycin, which is displayed here as oligomycin sensitive respiration. The G93A mutation
showed significantly reduced coupled respiration in comparison to the pIRES vector and G37R mutant cells. D. Mitochondrial proton leak. OCR in the
presence of rotenone subtracted from OCR in the presence of oligomycin determines proton leak. G37R showed significantly increased proton leak
compared to G93A and WTSOD1. E. Coupling efficiency (CE) ratio. Calculated by dividing the coupled respiration by mOCR. G93A SOD1 showed
significantly reduced CE ratio compared to the SOD1 mutations and WTSOD1. Data presented as mean with SD (n = 4). Statistical analyses by one-way
ANOVA with Bonferroni post-test, *** = P,0.001, ** = P,0.01, * = P,0.05.
doi:10.1371/journal.pone.0068256.g007
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The rate of mitochondrial ATP synthesis (ATP turnover) was
investigated by the application of oligomycin. The addition of
oligomycin shifts the entire cellular ATP synthesis towards
glycolysis so that subtraction of the post-treatment OCR from
bOCR indicates oligomycin sensitive respiration (coupled respira-
tion, Figure 3A). Overexpression of the different SOD1 mutations
produced different results in terms of mitochondrial-coupled
respiration. The G93A mutant cells showed significantly lower
ATP turnover (p#0.01) in comparison to the pIRES vector but
not WTSOD1 (Figure 7C), whilst the H48Q mutation showed no
difference in coupled respiration compared to controls. The G37R
mutation, however, showed significantly increased coupled respi-
ration compared to WT (p#0.05) and G93A SOD1 (p#0.001).
During ATP production, a percentage of protons leak across the
inner mitochondrial membrane. These protons are able to pass
back into the mitochondria, and in the absence of ATP synthesis
the proton circuit is largely completed by proton leak. Proton leak
can be determined by subtracting the respiration rate after the
application of rotenone from the oligomycin sensitive respiration
rate. No difference was observed between the G93A and H48Q
mutations and controls in terms of proton leak (Figure 7D).
However, the G37R mutant cells showed a significantly greater
(p#0.05) proton leak in comparison to the WTSOD1 cells.
Dysfunctional mitochondria are expected to show an increase in
proton leak as much of their energy generation is linked to
uncoupled respiration. Coupling efficiency ratio (CE ratio) is a
useful indicator of mitochondria dysfunction, as it is sensitive to
changes in mitochondrial bioenergetics and is an internally
normalised ratio [28]. Calculated by dividing the coupled
respiration by mOCR, CE ratio was significantly reduced in
G93A cells compared to WTSOD1 and the H48Q and G37R
SOD1 mutations (Figure 7E).
Difference in glycolytic flux between the mutations was also
investigated; however, no significant differences were observed for
basal ECAR between the controls and the mutations (data not
shown). The induction of ECAR in the presence of the
mitochondrial inhibitors oligomycin, FCCP and rotenone was
also measured to assess the glycolytic capacity of the cells.
However, there was no significant difference in glycolytic capacity
(p.0.05) between controls and mutant cells lines (data not shown).
Effect of Oxidative stress on Metabolic Function in NSC34
Cells
To assess the effect of SOD1 mutation on the metabolic
susceptibility to oxidative stress, the cell lines were subjected to
three sub-lethal doses of H2O2 (up to 200 mM for one hour) to
induce oxidative stress and to determine whether these conditions
introduced significant metabolic defects. Increasing levels of H2O2
led to a reduction of OCR in all cell lines (Figure 8A). However, a
significant reduction in basal OCR was observed for the G93A
mutant cells in comparison to the pIRES (p#0.05), WTSOD1
(p#0.01) and the G37R mutant cells (p#0.05) following treatment
with 100 mM H2O2 (Figure 8A).
Basal ECAR was unaffected in the control cells at 50 mM and
100 mM. However the G93A mutant cells showed a significant
reduction in ECAR at 100 mM (p#0.01) in comparison to both
the pIRES and WTSOD1 controls (Figure 8B), which may
indicate a susceptibility to oxidative stress caused by this particular
mutation. A reduction in ECAR was observed for both controls
and mutants at 200 mM. This data indicate that the G93A SOD1
mutation, unlike the G37R and H48Q mutations, confers a
metabolic susceptibility to oxidative stress, not only in terms of
cellular respiration but also glycolytic flux. 3-D Z-stack confocal
analysis of mitochondria morphology using rhodamine 123 (as
detailed in [29]) showed no significant differences between the
G93A SOD1 mutation and controls under both basal conditions
and following exposure to 100 mM H2O2 stress (data not shown).
Discussion
Defective respiratory chain function associated with oxidative
stress has previously been investigated in tissue from ALS patients
and in mutant SOD1 models, supporting its involvement in the
pathogenesis of this disease [30,31,32,33,34]. Here, using a motor
neuron-like cell model transfected with various human mutant
SOD1 transgenes to investigate the impact of oxidative stress on
cell viability and metabolic function, we show that the presence of
SOD1 mutations affects cell viability in response to oxidative stress
and impacts on metabolic function, with differences observed
between different SOD1 mutations. Cellular dysfunction through
oxidative stress plays a key role in MND disease progression. RT-
qPCR demonstrated equivalent levels of transfection for the
human wild-type and mutant SOD1 transgenes in NSC34s, at the
level of transcription. This data demonstrates the differences in
susceptibility to oxidative stress and mitochondrial function
Figure 8. The effect of oxidative stress on mitochondrial and
metabolic function. A. bOCR was measured following H2O2 stress.
The G93A mutation had significantly reduced oxygen consumption in
comparison to WTSOD1 and the G37R mutant human SOD1 after
100 mM stress. At 200 mM all cells displayed diminished basal OCR. B.
ECAR was measured following H2O2 stress. After H2O2 treatment the
G93A mutation displayed a significant reduction in ECAR at 100 mM in
comparison to both the vector and human SOD1 controls. Data
presented as mean with SD (n = 6), statistical analyses by two-way
ANOVA with Bonferroni post-test, ** = P,0.01, * = P,0.05.
doi:10.1371/journal.pone.0068256.g008
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identified in this study are not simply due to an over-expression of
the mutant transgene.
The G93A and G37R mutations are confined to the b-strands
of Cu/Zn SOD1, whereas the H48Q mutation is located in one of
the histidine residues that coordinate copper, reducing its affinity
for the ion. H48Q is superoxide dismutase inactive in comparison
to the G93A and G37R mutations, which display typical
enzymatic activity and bind copper in a coordination environment
similar to that of WTSOD1 [25,35,36,37]. Exposure to oxidative
stress revealed significant differences in terms of susceptibility to
cell death between the controls and SOD1 mutations, with the
G93A mutant cells showing the greatest susceptibility (Figure 1
and Figure 6). H48Q mutant cells were also increasingly
vulnerable following periods of more prolonged exposure to stress.
The G37R mutant cells, in contrast, showed an exponential
reduction in cell viability over time with increasing doses of
hydrogen peroxide, but maintained cell viability at a level equal to
or in some cases above that of the controls as shown by trypan blue
exclusion and the LDH assay (Figure 6).
There is evidence from both cellular and animal models of ALS
suggesting that SOD1 mutation leads to varying levels of cellular
toxicity depending on the mutation in question. ALS-associated
SOD1 mutations show the propensity to aggregate both with
there-self and other proteins, which may be a result of disruption
to the native protein folding [38]. A study investigating the
correlation between the propensity for aggregation and confor-
mational stability of SOD1 showed G93A to have the highest
conformation instability, and therefore more prone to aggregation,
in comparison to other SOD1 mutations, including G37R [39].
Another study also highlighted the differences between the
mutations in transgenic mouse models of ALS. The G93A mice
exhibited the fastest disease onset and had the shortest lifespan in
comparison to the G37R and H46R/H48Q mutations [40]. The
G37R mutation also seemed be less prone to forming insoluble
aggregates than the G93A mutation. This may be part of the
reason why the G93A mutation appeared more toxic in our study.
Dynein is crucial for axonal transport of mitochondria;
aggregated G93A SOD1 has been shown to bind to dynein and
this interaction has been proposed to facilitate the formation of
aggresome-like inclusions in the cell [41]. Interestingly, an H48Q
SOD1 mutation displayed a lower affinity for dynein compared to
G93A and was less prone to forming high molecular weight
complexes and large inclusions than the more toxic G93A
mutation.
Here we show the G93A mutation to be more susceptible to
oxidative stress induced cell death and mitochondrial dysfunction,
which may be a result of the increased toxicity of this mutation as
outlined here. In addition to this, G93A SOD1 have been shown
to bind mitochondria within the spinal cord of transgenic mouse
models of disease, forming high molecular weight aggregates,
which are subsequently bound by apoptotic regulator Bcl-2 [30].
The sequestration of Bcl-2 by mutant SOD1 aggregates will
render the protein non-functional, and inhibition of Bcl-2 binding
to pro-apoptotic proteins may reduce cellular viability. Bcl-2 is also
important for maintaining the mitochondrial membrane potential
[42], therefore its sequestration in to SOD1 aggregates may lead to
disruption of the mitochondrial membrane potential as observed
in this study (Figure 5). G37R SOD1 were also shown to bind Bcl-
2, but to a lesser degree [30].
Variations between the individual mutations likely underlie the
differences seen in susceptibility to oxidative stress in these
experiments. Phenotypic heterogeneity is also seen between
patients with different SOD1 mutations [43], adding further
complexity to studying the pathology of the disease. The rapid
induction of cell death following exposure to 500 mM and 1 mM
concentrations of H2O2 may indicate a sudden loss of, as-yet
undefined, compensatory mechanisms and an inability of the cells
to recover from the insult. The cells may be able to compensate at
lower concentrations, and hence only show minor reduction in
viability. The redox system is part of a complex signaling network.
Previous studies have shown that low concentration of ROS can
influence the regulation of intracellular signaling such as the
phosphoinositide 3-kinase (PI3K) pathway and the mitogen
activated protein kinase (MAPK) cascade [44,45] and which
potentially explain the maintained viability observed with moder-
ate H2O2 treatment. Previously published gene expression data
from our laboratory showed a greater downregulation of key
pentose phosphate metabolic enzyme activity in the G93A mutant
SOD1 NSC34 cells compared to WTSOD1 and G37R [22]. The
downregulation of the antioxidant response in G93A mutant cells
coupled with a high propensity of the mutant to aggregate in the
mitochondria may lead to higher ROS levels and increased
susceptibility to mitochondrial dysfunction and cell death in the
G93A SOD1 cells.
We also investigated the bioenergetic capacity of the NSC34
cells, to determine if the presence of disease-causing mutations had
differential effects on mitochondrial function that could be linked
to susceptibility to cell death under oxidative conditions. The
XF24 Seahorse Bioanalyser simultaneously measures aerobic
respiration and glycolysis within intact cells, and has previously
been used to investigate mitochondrial bioenergetics in Alzhei-
mer’s and Parkinson’s diseases [46,47,48]. Under basal culture
conditions, no extensive metabolic defects were observed between
controls and SOD1 mutants; the differences were subtle, with the
G93A mutation showing the greatest dysfunction. Although no
significant bOCR or mOCR defects were observed, the G93A
mutation showed reduced mitochondrial coupled respiration
compared to the pIRES and G37R cell lines (but not WTSOD1,
Figure 7 A–C). In addition, reduced coupling efficiency ratio was
observed for the G93A mutation compared to WTSOD1 and the
H48Q and G37R SOD1 mutations (Figure 7E). This indicates
differences in the efficiency of oxidative phosphorylation between
mutations and could explain why the G93A mutant cells show a
reduced mitochondrial membrane potential (Figure 5) and
increased susceptibility to oxidative stress in comparison to the
G37R mutant (Figure 6). Interestingly, the G37R SOD1 mutation
showed increased mitochondrial coupled respiration compared to
G93A and WTSOD1 but also increased proton leak compared to
the latter (Figure 7D). Small changes in uncoupling can have
physiological benefits by decreasing the mitochondrial membrane
potential and subsequently reducing ROS production, however,
large changes usually indicate damaged mitochondria [28]. It must
be noted that treatment with oligomycin leads to slight mitochon-
drial hyperpolarization, which may over-estimate the proton leak
and under-estimate ATP turnover; however in most cell types the
error is relatively small [49].
Previous work using the NSC34 cell model identified significant
reduction in the activity of complex II and IV of the mitochondrial
respiratory chain in cells transfected with G93A or G37R mutant
SOD1, in comparison to control vector-only cells [14]. No
significant differences were seen for complex I and III activity.
Defects in the mitochondrial membrane potential in G93A SOD1
transfected SH-SY5Y cells have also been observed [50].
However, another study found the activities of mitochondrial
ATP synthesis, cytochrome c oxidase, and citrate synthase were
unchanged in cells expressing G93A or G85R mutant SOD1 in
comparison to control cells [51], indicating not only the variability
in using different cell models to study disease but also the complex
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multi-factorial nature of the disease and how multiple factors are
likely to influence functional capacity. The lack of significant
reduction in total mitochondrial respiration observed in this study
may be due to the fact that we assessed mitochondrial function in
real time using intact cells, which gives greater physiological
relevance than measuring isolated mitochondrial complex activity.
The effect of oxidative stress on the bioenergetic profile of the
cells was investigated and significant differences in measurements
of ECAR and OCR were observed between the mutant-
transfected cell lines, again reflecting differences between muta-
tions (Figure 8). These assays were performed under sub-lethal
stress conditions (50 mM to 200 mM H2O2 for one hour).
Treatment with similar or lower doses for longer periods (although
not severe enough to induce cell death) may show different
responses of the mutants over time. Overall, the data suggest that
overexpression of the SOD1 G93A mutation renders the neuronal
cells not only more susceptible than controls to oxidative stress in
terms of cell survival, but in terms of increased susceptibility to
perturbations of mitochondrial respiration and glycolytic metab-
olism, since this was the only mutation to show significant
reductions in ECAR and OCR after H2O2 treatment.
The G93A SOD1 neuronal model has previously been shown to
have higher basal cellular oxidative stress than WTSOD1 and to
be more susceptible to serum withdrawn oxidative stress in terms
of cell survival [14,52]. Downregulation of key metabolic enzymes
in the pentose phosphate pathway, which produce NADPH,
essential for the cells antioxidant capacity, coupled with dysreg-
ulation of the antioxidant transcription factor NRF-2, may explain
why G93A cells are more susceptible to H2O2 induced oxidative
stress than vector alone or WTSOD1 overexpression [22]. In
addition to the defect in bOCR, we show here that the G93A
SOD1 cells have an increased metabolic susceptibility to oxidative
stress in terms of glycolytic flux. This, along with a previous study
showing that inhibition of glycolysis has a detrimental effect on cell
viability in G93A NSC34 cells [14] suggests that oxidative stress
not only leads to mitochondrial dysfunction in ALS but also
dysregulates key metabolic pathways such as glycolysis. Increases
in glycolytic flux would be crucial to compensate for the energy
deficit produced by mitochondrial dysfunction and protect the
neurone from oxidative stress induced cell death. Other in vitro
investigations suggest depletion of intracellular NAD pools and/or
of the inactivation of the glycolytic enzyme glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), due to oxidative stress, leads
to disruption of glycolysis [53,54]. Whilst the H2O2 generated by
the neurotoxin 6-hydroxydopamine has been shown to lead to the
loss of glycolytic activity via lipid peroxidation and inhibition of
lactate dehydrogenase in neuroblastoma N2-A cells [55].
Here we have applied a novel technique to investigate metabolic
function within intact motor neuronal NSC34 cells under basal
and oxidative stress conditions. Differences in cellular metabolic
and bioenergetic function between the mutations are consistent
with the differences observed in viability. The G93A mutation was
particularly susceptible to oxidative stress in terms of cell survival
and mitochondrial dysfunction, demonstrating significantly lower
OCR, spare respiratory capacity and mitochondrial respiration in
comparison to the G37R mutation, which was the least susceptible
to oxidative stress under the conditions investigated. Additionally,
G93A was the only SOD1 mutation to show significant changes in
OCR and ECAR under stress conditions. The H48Q mutation lay
between the G93A and G37R mutations in relation to mitochon-
drial bioenergetic capacity and susceptibility to oxidative stress.
This work contributes to the growing field of mitochondrial
bioenergetic dysfunction in motor neuron disease and future work
will address the underlying mechanisms by which these changes
occur.
Supporting Information
Figure S1 Transfection level of the human mutant
SOD1 transgenes were investigated by RT-qPCR. Com-
parison of the difference in threshold cycle (DCT) between the
human SOD1 transgene (SOD1) and a reference mouse Sod1 gene
(Sod1) showed no significant differences in the level of human
SOD1 between the cell lines. Data presented as mean with SD
(n= 3), statistical analyses by one-way ANOVA with Bonferroni
post-test.
(TIF)
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